Category: Clinical Trials

August 24, 2018

Clinical Trials Start-ups Polarean Imaging moving forward with Phase III trial of hyperpolarised 129-Xenon

  “Medical imaging technology company Polarean Imaging announced on Thursday...


October 16, 2019

Clinical Trials Start-ups PhaseBio Announces First Patient Dosed in Phase 2b Clinical Trial of PB2452 for Reversal of the Antiplatelet Activity of Ticagrelor

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on...


December 17, 2019

Clinical Trials Start-ups Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting

Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated...

Innavasc Senior Development Engineer, Criag Nichols and founder, Shawn Gage show off their puncture proof vascular graft to President Price. Photo by Jared Lazarus/Duke Photography

October 16, 2018

Clinical Trials Start-ups InnAVasc Medical preps for clinical trial with new funder

A Durham-based medical technology company is stocking up investment in...

Precision Biosciences Logo

April 8, 2020

Medicine Clinical Trials Start-ups Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A

Precision BioSciences, Inc. (DTIL), a life sciences company dedicated to...

Humacyte Phase II Vascular Trauma

October 30, 2018

Clinical Trials Start-ups Humacyte launches Phase II vascular trauma Humacyl vessel trial

Humacyte said yesterday it launched a U.S. Phase II trial of...


June 1, 2020

Clinical Trials Start-ups PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients

(Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development...

Grid Therapeutics Logo

June 24, 2020

Biotechnology Clinical Trials Start-ups Grid Therapeutics Announces Enrollment of 1st Patient in Phase 1 Study

Grid Therapeutics, LLC, a clinical-stage biotechnology company developing a first-in-class,...